Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma

doi:10.4251/wjgo.v15.i4.677

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2027)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

1175

Figures (1-2)

115

Tables (1-5)

110

Sum=1517

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

134

Download

376

Sum=510

Apr 15, 2023 (publication date) through Jul 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Apr 15, 2023; 15(4): 677-688
Published online Apr 15, 2023. doi: 10.4251/wjgo.v15.i4.677

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier estimates of disease-free survival (A) and overall survival (B) in patients with ampulla of Vater cancer according to the tumor, node, metastasis stage.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier curves for disease-free survival and overall survival by adjuvant chemotherapy. A: The median disease-free survival was 17.2 mo in the adjuvant chemotherapy group, as compared with 13.0 mo in the surgery-alone group; B: The median overall survival was 43.3 mo in the adjuvant chemotherapy group, as compared with 55.0 mo in the surgery-alone group; C: The median disease-free survival; and D: Overall survival in patients with stage II-III disease according to adjuvant chemotherapy.

Citation: Park SJ, Shin K, Kim IH, Hong TH, Kim Y, Lee MA. Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma. World J Gastrointest Oncol 2023; 15(4): 677-688
URL: https://www.wjgnet.com/1948-5204/full/v15/i4/677.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i4.677